厄贝沙坦通过调节NLRP3表达在糖尿病肾病大鼠中的保护作用

Protective Effect of Irbesartan in Diabetic Nephropathy Rats Through Regulating NLRP3

目的 观察糖尿病肾病大鼠中NLRP3(NOD-like receptor protein 3)的表达,并在沉默NLRP3和以血管紧张素受体抑制剂(ARB)厄贝沙坦干预后观察NLRP3及炎症和纤维化因子的表达变化,探讨厄贝沙坦对糖尿病肾病大鼠的保护作用。方法 雄性SD大鼠随机分成5组:对照(Control)组、模型(Model)组、空载(Model+Blank)组、NLRP3沉默(Model+NLRP3 Sh)组、ARB(Model+ARB)组,分别在糖尿病肾病模型建立后8周、12周处死大鼠并收集肾脏组织。实时荧光定量PCR检测NLRP3、半胱氨酸天冬氨酸蛋白酶-1(Caspase-1)、核因子κB(NF-κB)P65和波形蛋白(Vimentin)的mRNA表达水平;Western blot检测NLRP3、P65、热休克蛋白47(heat shock protein 47,HSP47)和Vimentin的蛋白表达水平;免疫荧光法观察NLRP3、Caspase-1和Vimentin的表达;PAS、PASM和Masson染色观察肾脏病理改变。结果 与对照组比较,模型组及空载组NLRP3、Caspase-1、P65和Vimentin mRNA的表达升高(均P<0.05),NLRP3、Caspase-1、P65、HSP47和Vimentin的蛋白表达升高(均P<0.05)。与模型组及空载组相比,NLRP3沉默组及ARB组的上述指标表达均下调(均P<0.05),模型组与空载组以上指标之间差异无统计学意义。病理染色结果显示NLRP3沉默和厄贝沙坦干预可减轻糖尿病肾病大鼠肾脏损害,减轻肾小球肥大、肾小球硬化、系膜扩张、间质纤维化。结论 糖尿病肾病大鼠肾脏NLRP3信号通路被激活,且炎性和纤维化因子表达上调。厄贝沙坦可阻断NLRP3信号通路,减轻肾脏损害。天然免疫受体NLRP3可能成为治疗糖尿病肾病的新靶点。

Objective To observe the expression of NLRP3(NOD-like receptor protein 3)in diabetes nephropathy rats,and observe changes in expression of inflammatory and fibrosis factors after NLRP3 silencing and irbesartan(ARB)intervention,so as to explore the protective effect of irbesartan on diabetic nephropathy rats.Methods Male SD rats were randomly divided into 5 groups:Control group,Model group,Model+Blank group,Model+NLRP3 Sh group and Model+ARB group.The rats were killed 8 weeks and 12 weeks after the establishment of diabetes nephropathy model,and the kidney tissues were collected.Real-time PCR was used to detect the mRNA expression of NLRP3,Caspase-1,P65 and Vimentin.Western blot was used to detect the protein expression of NLRP3,P65,HSP47 and Vimentin.Immunofluorescence was used to observe the expression of NL-RP3,Caspase-1 and Vimentin.PAS,PASM and Masson staining were used to observe the pathological changes of kid-ney.Results Compared with Control group,the mRNA expressions of NLRP3,Caspase-1,P65 and Vimentin were increased(all P<0.05),and the protein expressions of NLRP3,Caspase-1,P65,HSP47 and Vimentin were increased in Model group and Model+Blank group(all P<o.05).Compared with Model group and Model+Blank group,the above indicators were decreased in Model+NLRP3 Sh group and Model+ARB group(all P<o.05).And the differences of above indicators between Model group and Model+Blank group were statistically insignificant.The pathological staining results showed that NLRP3 silencing and ARB intervention inhibited the renal damage of diabetic rats,and relieved the glomerular hypertrophy,glomerular sclerosis,basement membrane expansion,and interstitial fi-brosis.Conclusion NLRP3 signaling pathway is activated in the kidney of diabetes nephropathy rats,and the expression of inflammatory and fibrosis factors is upregulated.Irbesartan can block NLRP3 signaling pathway and alleviate renal damage.Innate immune receptor NLRP3 may become a new therapeutic target for diabetes nephropathy.